ExploreTreatments
NAD+ Therapy ComparisonExpert analysis updated June 2026

DirectMeds vs Sprout Health: NAD+ Injection Comparison (2026)

DirectMeds and Sprout Health are two of the most pricing-transparent NAD+ injection programs in the market. DirectMeds starts at $99 for the first month (500mg) and renews at $199, with no automatic billing and manual reordering. Sprout Health is fully disclosed at $149 for the first month and $240 every four weeks for 1,000mg, with a full home kit and free shipping included.

Our Verdict

DirectMeds is the stronger pick for most readers: a lower $99 first month, two dose options, no automatic billing, and a very large public review base. Sprout Health appeals to readers who want the most complete upfront disclosure of dose, renewal, and included kit, and who are comfortable with its higher $240 four-week renewal.

Side-by-Side Feature Comparison

FeatureDirectMedsSprout HealthWinner
First-Month Price$99 first month (500mg)$149 first monthDirectMeds
Renewal Price$199/mo (500mg) / $249 (1,000mg)$240 every 4 weeksDirectMeds
Billing ModelNo automatic billing, manual reorderSubscription with auto-renewalDirectMeds
Dose Options500mg and 1,000mg1,000mg onlyDirectMeds
Delivery FormatInjection onlyInjection onlyTie
ShippingFast shipping includedFree shipping includedTie
Public Reviews4.6/5 (10,155 on Trustpilot)3.4/5 (94 on Trustpilot)DirectMeds
Included CareAll-inclusive care and suppliesConsultation and full home injection kitTie

Pros and Cons

DirectMeds

Pros

  • Lower $99 first month (500mg)
  • Two dose options: 500mg and 1,000mg
  • No automatic billing, you reorder manually
  • Very large positive review base (4.6/5, 10,155 reviews)
  • All-inclusive care and fast shipping

Cons

  • Injection-only, no nasal or oral format
  • 1,000mg renewal reaches $249

Best For

Readers who want exact pricing, two dose options, and control over reordering with no automatic billing.

Sprout Health

Pros

  • Exact dose, introductory price, and renewal are all public
  • Consultation, full home injection kit, and free shipping included
  • Clear cancellation and auto-renewal terms
  • 1,000mg dose disclosed upfront

Cons

  • $240 every four weeks is a relatively high renewal
  • Injection is the only public format
  • Small public review base (94 reviews)

Best For

Readers who want the most complete upfront disclosure of dose, renewal, and included kit, and accept a higher four-week renewal.

Frequently Asked Questions: DirectMeds vs Sprout Health

DirectMeds is cheaper to start at $99 for the first month (500mg) versus $149 at Sprout Health. On renewal, DirectMeds is $199/month for 500mg ($249 for 1,000mg), while Sprout Health is $240 every four weeks for 1,000mg. Always weigh the first-month price against the renewal.
DirectMeds does not use automatic billing, you reorder manually when you choose. Sprout Health uses a subscription with auto-renewal, though it discloses its cancellation and renewal terms clearly upfront.
Sprout Health offers a 1,000mg injection. DirectMeds offers both 500mg and 1,000mg options. Both are injection-only programs with no nasal or oral format.

NAD+ Therapy Guides

Compare All NAD+ Therapy Providers

See the full ranked list of nad+ therapy providers side-by-side with ratings and pricing.

View All Providers

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.

Editorial Standards: Independent research · Evidence-based analysis · Transparent methodology · 2026